Literature DB >> 19659678

Ketamine-associated bladder dysfunction.

Tsung-Hsun Tsai1, Tai-Lung Cha, Chang-Min Lin, Chih-Wei Tsao, Shou-Hung Tang, Feng-Pin Chuang, Sheng-Tang Wu, Guang-Huan Sun, Dah-Shyong Yu, Sun-Yran Chang.   

Abstract

OBJECTIVE: To assess the impact of ketamine abuse on genitourinary tract dysfunction.
METHODS: Eleven patients with urinary tract symptoms and a history of ketamine abuse in recent years were studied. Urinalysis, urine culture, renal function tests, abdominal sonography and urodynamic studies were done. Bladder biopsies were carried out in selected cases.
RESULTS: The most common complaints were lower urinary tract symptoms, including dysuria, frequency, urgency and gross hematuria. Urinalyses showed nonbacterial pyuria and were negative for tuberculosis. All biopsy specimens showed infiltrations of granulocytes (mostly eosinophils) and mast cells within the bladder tissue. Medications produced only slight clinical improvements. Intravesical instillation of hyaluronan solution was performed for some patients and a significant improvement of lower urinary tract symptoms was observed.
CONCLUSIONS: Although the dosage and duration of ketamine abuse causing severe side-effects are still unclear, some patients develop irreversible histological changes in the urinary tract. Therefore, clinicians should be aware of the negative effects of ketamine abuse on genitourinary tract function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19659678     DOI: 10.1111/j.1442-2042.2009.02361.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  35 in total

1.  Clinical staging of ketamine-associated urinary dysfunction: a strategy for assessment and treatment.

Authors:  Peng Wu; Qiang Wang; Zehai Huang; Junpeng Wang; Qinghui Wu; Tianxin Lin
Journal:  World J Urol       Date:  2016-01-23       Impact factor: 4.226

Review 2.  Ketamine for chronic pain: risks and benefits.

Authors:  Marieke Niesters; Christian Martini; Albert Dahan
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

3.  Illicit ketamine and its bladder consequences: is it irreversible?

Authors:  Rozh Jalil; Suresh Gupta
Journal:  BMJ Case Rep       Date:  2012-10-30

4.  Chronic ketamine treatment-induced changes in contractility characteristics of the mouse detrusor.

Authors:  Hong Chai Tang; Wai Ping Lam; Xin Zhang; Ping-Chung Leung; David T Yew; Willmann Liang
Journal:  Int Urol Nephrol       Date:  2014-03-12       Impact factor: 2.370

Review 5.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

6.  Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine.

Authors:  David M Wood; Susannah Davies; Malgorzata Puchnarewicz; Atholl Johnston; Paul I Dargan
Journal:  Eur J Clin Pharmacol       Date:  2011-12-29       Impact factor: 2.953

7.  Ketamine-associated ulcerative cystitis: a case report and literature review.

Authors:  Christopher Chee Kong Ho; Hafez Pezhman; Singam Praveen; Eng Hong Goh; Boon Cheok Lee; Md Zainuddin Zulkifli; Mohamed Rose Isa
Journal:  Malays J Med Sci       Date:  2010-04

Review 8.  [Ketamine in the therapy of chronic pain and depression].

Authors:  Wolfgang Jaksch; Rudolf Likar; Martin Aigner
Journal:  Wien Med Wochenschr       Date:  2019-04-12

9.  The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore.

Authors:  Jacklyn Yek; Palaniappan Sundaram; Hakan Aydin; Tricia Kuo; Lay Guat Ng
Journal:  Singapore Med J       Date:  2015-12       Impact factor: 1.858

10.  A pilot study of urine cytokines in ketamine-associated lower urinary tract symptoms.

Authors:  Rachel Y K Cheung; Jacqueline H S Lee; Symphorosa S C Chan; Dawn W T Liu; K W Choy
Journal:  Int Urogynecol J       Date:  2014-06-28       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.